Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
60.89
-0.43 (-0.70%)
Aug 10, 2026, 4:00 PM EDT - Market closed
Travere Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -86.93 | -51.09 | -643.09 | -222.8 | -556.96 | -360.18 |
Depreciation & Amortization | 63.37 | 60.74 | 43.56 | 38.53 | 20.72 | 12.75 |
Stock-Based Compensation | 60.66 | 44.87 | 36.91 | 44.25 | 38.14 | 29.57 |
Other Adjustments | -3.38 | -3.57 | 73.16 | -6.33 | 10.89 | 17.97 |
Change in Receivables | -16.92 | -27.82 | -6 | -11.26 | -1.06 | 0.85 |
Changes in Inventories | -2.08 | 5.02 | -3.77 | -39.42 | -1.21 | 0.12 |
Changes in Accounts Payable | -12.07 | -0.09 | -17.56 | 24.76 | 2.06 | 2.47 |
Changes in Accrued Expenses | 46.23 | 28.84 | -31.06 | 22.32 | 22.18 | 16.68 |
Changes in Income Taxes Payable | - | 0.85 | -0.04 | -0.04 | -0.37 | 17.1 |
Changes in Unearned Revenue | - | -2.82 | -6.12 | -15.78 | -12.93 | 38.3 |
Changes in Other Operating Activities | -16.68 | -17.98 | 1.53 | -6.06 | -7.79 | 5.26 |
Operating Cash Flow | 92.7 | 37.78 | -237.48 | -280.02 | -186.29 | -14.79 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | - | - | - | - | - | -5.1 |
Purchases of Intangible Assets | -77.54 | -58.16 | -36.21 | -41.59 | -28.37 | -19.05 |
Purchases of Investments | -399.41 | -237.14 | -125.76 | -443.94 | -385.39 | -547.08 |
Proceeds from Sale of Investments | 274.19 | 323.6 | 326.33 | 334.58 | 381.99 | 433.6 |
Cash Acquisitions | - | - | -65 | - | - | - |
Other Investing Activities | -0.47 | -0.4 | -0.04 | -0.67 | -0.79 | - |
Investing Cash Flow | -202.99 | 27.89 | 99.33 | 55.78 | -32.55 | -137.62 |
Long-Term Debt Issued | - | - | - | - | 316.25 | - |
Long-Term Debt Repaid | - | -68.9 | - | - | -211.32 | - |
Net Long-Term Debt Issued (Repaid) | - | -68.9 | - | - | 104.93 | - |
Issuance of Common Stock | 66.22 | 37.54 | 141.52 | 222.23 | 27.11 | 239.89 |
Net Common Stock Issued (Repurchased) | 66.22 | 37.54 | 141.52 | 222.23 | 27.11 | 239.89 |
Other Financing Activities | -2.1 | -2.1 | -2.1 | -2.1 | -11.98 | -2.1 |
Financing Cash Flow | 153.06 | -33.47 | 139.42 | 218.75 | 117.57 | 231.68 |
Foreign Exchange Rate Adjustments | -0.19 | 2.29 | -0.91 | 1.98 | -2.79 | 1.71 |
Net Cash Flow | 42.58 | 34.5 | 0.36 | -3.51 | -104.07 | 80.98 |
Free Cash Flow | 92.7 | 37.78 | -237.48 | -280.02 | -186.29 | -19.89 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | 15.68% | 7.70% | -101.84% | -192.80% | -170.19% | -15.09% |
Free Cash Flow Per Share | 0.98 | 0.42 | -3.01 | -3.77 | -2.92 | -0.33 |
Levered Free Cash Flow | 35.31 | -19.88 | -335.01 | -87.08 | -150.9 | -92.52 |
Unlevered Free Cash Flow | 38.51 | 10.48 | -337.41 | -364.05 | -297.46 | -112.23 |